Descriptive Study of a French Sample of "at Risk" and Pathological Gamblers Followed in a French Structure Specialised in Addictive Disorders.
NCT00360321 · Status: UNKNOWN · Type: OBSERVATIONAL
Last updated 2006-08-04
Summary
International surveys about pathological gambling estimate that there are about 1 to 3 per cent of gamblers who develop a pathological behavior about gamble.In France, pathological gambling is not a priority of public health, in contrast with other addictive disorders, like alcoholism or nicotine addiction. The aim of our study is to describe accurately for the first time in France, a sample of "at risk" and pathological French gamblers. We want to collect socio-demographical and clinical data from this subjects (story of the addictive behaviour, co morbidities, and more specifically, detailed study of pathological gamblers' personality), in order to compare our data with those of international literature.Secondarily, we want to test the feasibility of this kind of detailed evaluations for another study planned for 2007-2008 and which purpose will be to compare pathological gamblers' personality characteristics according to the kind of game that they mainly practice.The participation at the study will be proposed to every patient consulting in the "service d'addictologie du CHU de Nantes". The study consists in a single evaluation (about 8 hours) with standardized tools used all other the world.
Conditions
- Pathological Gambling
Sponsors & Collaborators
-
Nantes University Hospital
lead OTHER
Principal Investigators
-
Venisse Jean Luc, Professor · Nantes University Hospital
Eligibility
- Min Age
- 0 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Study of Addiction Criteria in the Elderly
NCT03509077 ·Status: UNKNOWN
-
NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions
NCT05540288 ·Status: RECRUITING ·Phase: PHASE3
-
Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder
NCT03430180 ·Status: UNKNOWN ·Phase: PHASE2
-
Addictology Expert Patients' Fields of Intervention
NCT04458987 ·Status: COMPLETED ·Phase: NA
-
Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling
NCT00326807 ·Status: COMPLETED ·Phase: NA
-
Investigation of Naltrexone for Pathological Gambling
NCT01057862 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Familiarity in Alcohol Dependence
NCT02881424 ·Status: TERMINATED
-
Study of the BDNF-Val66Met Polymorphism in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal
NCT02146963 ·Status: COMPLETED
-
Semantic Networks in Alcohol Use Disorder Patients: Exploratory Study
NCT05636033 ·Status: COMPLETED
-
Dietary Fiber Intake in Alcohol-dependent Patients
NCT03803709 ·Status: UNKNOWN ·Phase: NA
-
Consequences of At-risk Alcohol Consumption in ICU Patients
NCT03565016 ·Status: COMPLETED
-
Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU
NCT02723383 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacological Treatment for Alcoholism
NCT00382642 ·Status: COMPLETED ·Phase: PHASE3
-
Acamprosate in the Treatment of Pathological Gambling
NCT00571103 ·Status: COMPLETED ·Phase: PHASE4
-
Cognitive Remediation in Alcohol Disorders
NCT03335215 ·Status: UNKNOWN ·Phase: NA
-
Baclofen for the Treatment of Alcohol Drinkers
NCT01604330 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Tolerability and Effects of AZD0530 in Individuals With or Without a Family History of Alcoholism
NCT02262026 ·Status: COMPLETED ·Phase: PHASE1
-
Screening for Alcohol-related Cognitive Impairments in Cirrhotic Patients
NCT04490330 ·Status: UNKNOWN
-
Pregabalin for Alcohol Dependence
NCT02205879 ·Status: COMPLETED ·Phase: PHASE4
-
Validation of the Ontological Addiction Scale
NCT04137471 ·Status: COMPLETED
-
From Uncomplicated Alcoholism to Korsakoff's Syndrome
NCT01455207 ·Status: UNKNOWN ·Phase: NA
-
Observational Study on Patients With Baclofen Treatment for Alcohol-dependence in France
NCT02835365 ·Status: COMPLETED
-
Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment
NCT05855668 ·Status: RECRUITING ·Phase: NA
-
The Effects of Treatment With Naltrexone in Alcohol and Cannabis-dependent Patients
NCT01560013 ·Status: UNKNOWN ·Phase: NA
-
Effect of Anti-craving Medication on Cognitive Functions in Alcohol Dependence: an ERP Study
NCT02107352 ·Status: COMPLETED